Download an MS-Word copy of this page

Laura Newman: email [email protected]
1
Selected Writing Samples
Oncology
Ensuring patient safety, credibility in clinical trials. Journal of Oncology Practice. 2007.
Preparing for Community Clinical Oncology Program budget cuts. Journal of Oncology Practice.
June 2007:219-220.
Clinical cancer advances 2006:major research advances in cancer treatment, prevention, and
screening. Journal of Oncology Practice. May 2007.
Despite efficacy of prophylactic mastectomy, procedure lacks few enthusiasts. J Natl Cancer
Inst. 2001;93(5):338-9.
Triple therapy offers local control of high-risk PCA. Urology Times. Sept. 2003.
Prophylactic oophorectomy in the genome age: balancing new data against uncertainties. J
Natl. Cancer Inst. 2001;93(3):173-5.
Developing technologies for the early detection of breast cancer. Institute of Medicine. National
Academies Press, 2001.
Studies raise questions about link between HPC2 Gene and PCA. Urology Times, July 1, 2001.
Intravescical gemcitabine shows promise for TCC. Urology Times. May 1, 2002.
Larger debate underlies spiral CT screening for lung cancer. Journal National Cancer Inst..
2000 April 19; 92(8): 592-4.
Sentinel lymph node biopsy: is omitting regional lymph node biopsy justifiable? Dermatology
Times. Sept. 1, 2004.
New tumor markers and melanoma: study shows potential clinical urility. Dermatology Times.
May 1, 2004.
Triple therapy offers local control for high-risk prostate cancers. Urology Times. Sept. 1, 2003,
Novel proteomics test detects 95% of prostate cancers. Urology Times. Dec. 2002.
Nomogram for predicting PCa recurrence is validated. Urology Times. Dec. 2002.
Second cancer network [National Comprehensive Cancer Network] meeting tackles wooing
managed care. Report from the field. Medical Outcomes & Guidelines Alert. March 14, 1997.
Laura Newman: email [email protected]
New HRT outcomes studies offer guidance on screening for endometrial cancer. Rx outcomes
report. Medical Outcomes & Guidelines Alert. January 22, 1998.
Neurology
DA advisory panel recommends approval of Tysabri, Appl Neurol. April 2006.
Oxford study finds strokes more frequent than heart attacks. Emerg Med News. April 2006.
Neutralizing antibodies to Interferon: clinically relevant to MS treatment. Applied Neurol. Oct.
2005.
Postoperative chemotherapy bolsters five-year outcomes in early childhood medulloblastomas.
Neurology Today. 2005. 5; (7):67.
First workshop on MS research sets research priorities. Neurology Today. 2005; 5(7): 57.
Career opportunities expand in cancer pain and palliative care. Appl Neurol. June 2005
Chronic Illnesses
US Institute of Medicine urges more HIV-Prevention efforts. Lancet. 2000; 356:1252.
New Dartmouth Atlas: improving US cardiac care? Lancet. 2000. 356: 660.
Should diabetics with chest pain be triaged differently? Researchers find no difference in postadmission complication rates. WebMD Medical News. March 24, 2000.
Cardiac troponin levels and heart failure: is the data in? WebMD Medical News. Oct. 7, 1999.
Etanercept for juvenile rheumatoid arthritis demonstrates effectiveness in battling treatment
refractory disease. March 15, 2000.
ACC, AHA, ACP-ASIM join forces on chronic stable angina guidelines. Medical Outcomes &
Guidelines Alert. July 1, 1999.
Prescribing errors escalate with complex HIV regimens. Medical Outcomes & Guidelines Alert.
October 8, 1998.
Imaging
2
Laura Newman: email [email protected]
3
The next wave in breast cancer management. Medical Solutions. Dec. 2007.
The next frontier: an integrated medical information technology platform. Medical Solutions.
Larger debate underlies spiral CT screening for lung cancer. J Natl Cancer Inst. 2000;
92(8):592-4.
Seed targeting improved with hybrid imaging techniques.Urology Times. Sept. 2003.
CT vs. CT-MR: Which method is better post-implant? Uoology Times. Set. 2003.
Brain spectroscopy shows metabolic changes in patients with major depression. WebMD
Medical News. November 15, 2000.
Health Policy and Clinical Practice
Weighing the impact of the Health Insurance Portability and Accountability Act on clinical
research. JOP.
Medicare Part D prompts formulary concerns. Appl Neurol. Aug. 2006.
Medicare coverage group assesses effectiveness of new technologies. J Natl Cancer Inst.
2001; 93(11):805-806.
AHRQ's evidence-based practice centres prove viable. Agency for Healthcare Research and
Quality. Lancet. 2000;356(9246):1999.
New twist on guideline dissemination stirs professional debate, gets slap from FDA. Medicine &
Health. Perspectives. February 22, 1998.
Translating evidence into practice: experts see a thorny road ahead. Medical Outcomes &
Guidelines Alert. August 7, 1997.
Amid genetic advances, plans must wrestle with complex challenges. Medical Outcomes &
Guidelines Alert. November 6, 1997.
At the FDA, new use initiative could signal major transition. Rx Outcomes Report. Medical
Outcomes & Guidelines Alert. March 21, 1997.
Outcomes research: a missing link in formulary decisions. Rx Outcomes Report. Medical
Outcomes & Guidelines Alert. August 7, 1997.
Laura Newman: email [email protected]
4
ISPOR aiming to be worldwide authority on pharmacoeconomics. Report from the field. Medical
Outcomes & Guidelines Alert. May 11, 1997.
Clinical Trials
Prepare and plan for fiscal constraints on clinical trials. J Oncol Pract. Jan. 2007.
Ensuring patient safety, credibility in clinical trials. J Oncol Pract. 2007.
Temozolomide trials set new standard of care for recently diagnosed gliomas. Neurology Today.
2005; 5(6):26, 30.
Bladder cancer chemotherapy trial generates more questions than it answers. Journal National
Cancer Institute 2001 July 4; 93(13)973-5.
Surgical oncology focusing on minimally invasive surgeries, more randomized controlled clinical
trials. Journal National Cancer Institute 2001 June 20;93(12):897-900.
It's their turn now: older women are subject of landmark clinical trial. Medical Outcomes &
Guidelines Alert. January 22, 1998.
HRT and secondary prevention of CHD: trial finds no overall benefit. Medical Outcomes &
Guidelines Alert. September 10, 1998.
Is dearth of diabetes drug trials compromising safety? Rx outcomes report. Medical Outcomes &
Guidelines Alert. May 21, 1998.
Profiles
Maurice Hilleman: microbe hunter, virologist, and the twentieth-century's leading vaccinologist.
BMJ. April 2005; 330:102.
Elisabeth Kubler-Ross: psychiatrist and pioneer of the death-and-dying movement. BMJ.
September 2004; 329:627.>
Brandt Steele: psychiatrist who defined ïbattered child syndromeï and spearheaded child
protection movement. BMJ. 2004;329.
Andrew von Eschenbach takes helm at the National Cancer Institute. The Scientist. April 2002.
John Meyer Eisenberg: advocate of evidence based health care who led moves to reduce
medical errors and improve patient safety. BMJ. March 2002; 324:793.
Laura Newman: email [email protected]
Jeffrey Isner: pioneer of cardiovascular gene therapy dies at 53. BMJ. 2001; 323:1310.
5